GATA3: A promising marker for metastatic breast carcinoma in serous effusion specimens

Publisher： John Wiley & Sons Inc

E-ISSN： 1934-6638|122|4|307-312

ISSN： 1934-662x

Source： CANCER CYTOPATHOLOGY, Vol.122, Iss.4, 2014-04, pp. : 307-312

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Utility of GATA3 immunohistochemistry for diagnosis of metastatic breast carcinoma in cytology specimens

By  

DIAGNOSTIC CYTOPATHOLOGY, Vol. 43, Iss. 4, 2015-04 ,pp. : 271-277

John Wiley & Sons Inc

Access to resources Recommend Favorite

Usefulness of GATA3 and p40 immunostains in the diagnosis of metastatic urothelial carcinoma in cytology specimens

By  

CANCER CYTOPATHOLOGY, Vol. 122, Iss. 6, 2014-06 ,pp. : 468-473

John Wiley & Sons Inc

Access to resources Recommend Favorite

Evaluation of androgen receptor and GATA binding protein 3 as immunohistochemical markers in the diagnosis of metastatic breast carcinoma to the lung

By  

PATHOLOGY INTERNATIONAL, Vol. 65, Iss. 6, 2015-06 ,pp. : 286-292

John Wiley & Sons Inc

Access to resources Recommend Favorite

Metastatic serous carcinoma presenting as inflammatory carcinoma over the breast—Report of two cases and literature review

By  

JOURNAL OF CUTANEOUS PATHOLOGY, Vol. 45, Iss. 3, 2018-03 ,pp. : 234-239

John Wiley & Sons Inc

Access to resources Recommend Favorite

Young investigator challenge: The utility of GATA3 immunohistochemistry in the evaluation of metastatic breast carcinomas in malignant effusions

By  

CANCER CYTOPATHOLOGY, Vol. 123, Iss. 10, 2015-10 ,pp. : 576-581

John Wiley & Sons Inc

Access to resources Recommend Favorite